EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

An overview of BAP1 biological functions and current therapeutics

Abdelrahman M Elsayed, Muaiad Kittaneh, Colleen M Cebulla, Mohamed H Abdel-Rahman

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-04 · 1880 (2) · 189267

DOI: 10.1016/j.bbcan.2025.189267 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-04. Verfasst von Abdelrahman M Elsayed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Depa…. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Tumor Suppressor Proteins, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Foundation for the National Institutes of Health, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1-associated protein 1 (BAP1) is a tumor suppressor gene that was first identified in 1998. Germline loss-of-function variants in BAP1 are associated with a tumor predisposition syndrome with at least four cancers: uveal melanoma (UM), malignant mesothelioma (MMe), renal cell carcinoma (RCC), and cutaneous melanoma (CM). Furthermore, somatic BAP1 mutations are important drivers for several cancers most notably UM, MMe, RCC, intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Emerging evidence substantiates the fundamental role of BAP1 in suppressing cancer initiation and progression by tuning DNA damage repair, apoptosis, ferroptosis, immune response, Warburg phenomenon, and metastasis. Multiple treatment strategies such as poly (ADP-ribose) polymerase (PARP) inhibitors, EZH2 inhibitors, alkylating agents, and immunotherapy have been used as potential therapies for BAP1-mutated tumors. Although these agents showed promising results in BAP1-mutated tumors in preclinical studies, the results of most clinical trials are still dismal. The objectives of this review are to summarize the current state of knowledge regarding the biological functions of BAP1, the implications of these functions in tumorigenesis, and the current progress in BAP1-targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin ThiolesteraseTumor Suppressor ProteinsNeoplasmsHumansAnimalsMutation

Stichwörter der Autor:innen

Alkylating agentBRCA1-associated protein 1 (BAP1)EZH2 inhibitorsHDAC inhibitorsImmunotherapyPARP inhibitorsTherapeutics

Substanzen

Ubiquitin ThiolesteraseBAP1 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar U…
  • Department of Oncology, Loyola University Chicago, Maywood, IL 60660, USA.
  • Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Electronic address: colleen.cebulla@osumc.edu.
  • Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Division of Human Genetics, Department of Internal Medicine, The Ohio Stat…

Förderung

  • NCI NIH HHS
  • Foundation for the National Institutes of Health
  • National Institutes of Health
  • US Department of Defense

Zitieren

APA

Elsayed, A. M., Kittaneh, M., Cebulla, C. M., & Abdel-Rahman, M. H. (2025). An overview of BAP1 biological functions and current therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(2), 189267. https://doi.org/10.1016/j.bbcan.2025.189267

Vancouver

Elsayed AM, Kittaneh M, Cebulla CM, Abdel-Rahman MH. An overview of BAP1 biological functions and current therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(2):189267. doi:10.1016/j.bbcan.2025.189267

BibTeX
@article{Elsayed2025,
  author = {Elsayed, Abdelrahman M and Kittaneh, Muaiad and Cebulla, Colleen M and Abdel-Rahman, Mohamed H},
  title = {An overview of BAP1 biological functions and current therapeutics},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  volume = {1880},
  number = {2},
  pages = {189267},
  doi = {10.1016/j.bbcan.2025.189267}
}
Kostenlos starten →